Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
Sylvie Boutin, Virginie Monteilhet, Philippe Veron, Christian Leborgne, Olivier Benvéniste, M. Montus, Carole Masurier
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1089/hum.2009.182
- Published
- Jan 22, 2010
- Venue
- Human Gene Therapy
- DOI
- 10.1089/hum.2009.182
- PubMed
- 20095819
- Categories
- Virus-based gene therapy research
- Provenance
- openalex